ORGANON (IRELAND) LIMITED

Organon (Ireland) Limited is an independent global healthcare company dedicated to improving women's health throughout every stage of life. With a portfolio of more than 70 medicines and medical devices, Organon delivers therapies across a wide spectrum of therapeutic areas, including reproductive health, cardiovascular disease, neurology, dermatology, autoimmune and respiratory conditions. The company's products reach over 140 markets, ensuring that essential treatments are accessible to patients worldwide.

The business is built around three core pillars. In women's health, Organon focuses on conditions that are unique to, disproportionately affect, or impact women differently-such as fertility, contraception, maternal health and vaginal health. Its biosimilar programme expands treatment options by providing cost-effective alternatives for patients, providers and health-care systems. Established brands round out the offering, covering cardiovascular, respiratory, dermatology, central nervous system disorders, bone health, immunology, non-opioid pain management, menopause and more.

Guided by the vision of "a better and healthier every day for every woman," Organon combines scientific innovation with a commitment to accessibility, aiming to create a brighter, more resilient future for women and the communities they support.